Press releaseACCESS Newswire
Xenetic Biosciences
XBIO · NASDAQ
$2.00+$0.07 (+3.63%)TodayMarket closed ·
Prev close $1.93
Latest news
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- NewsAvi Kapoor
Crude Oil Down Over 3%; US Business Inventories Surge In July
- NewsVandana Singh
Micro Cap Xenetic Biosciences Expands Therapeutic Platform With Santersus Acquisition
- Press releaseACCESS Newswire
Xenetic Biosciences and Santersus AG Announce Definitive Share Exchange Agreement to Create Global Leader in NET-Targeting Therapeutics
- Press releaseACCESS Newswire
Xenetic Biosciences Reports Second Quarter 2026 Financial Results and Highlights Strengthened Scientific Foundation Supporting Continued Advancement of Proprietary DNase Platform
- Press releaseACCESS Newswire
Xenetic Biosciences, Inc. Announces That Its Collaboration Partner Received Approval From the Israeli Ministry of Health to Conduct Exploratory, Investigator Initiated Study of DNase I In Combination With Anti-CD19 CAR T Cells in Large B-Cell Lymphoma
- Press releaseACCESS Newswire
Xenetic Biosciences Showcases Compelling ASCO 2026 Data Demonstrating DNase I Significantly Enhances CAR-T Cell Persistence, Tumor Control, and Survival
- Press releaseACCESS Newswire
Xenetic Biosciences Reports First Quarter 2026 Financial Results and Highlights Continued Advancement of DNase Oncology Platform
- News
12 Health Care Stocks Moving In Friday's Pre-Market Session
- Press releaseACCESS Newswire
Xenetic Biosciences, Inc. Reports Full Year 2025 Financial Results
- Press releaseACCESS Newswire
Xenetic Biosciences, Inc. Announces Adjournment of 2025 Annual Meeting
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- Press releaseACCESS Newswire
Xenetic Biosciences, Inc. Extends Research and Development Collaboration with Institute Investigator at Scripps Research to Advance DNase Platform
- Press releaseACCESS Newswire
Xenetic Biosciences, Inc. Reports Third Quarter 2025 Financial Results
- NewsHenry Khederian
Micron, Galecto And Xenetic Lead This Week's Benzinga Stock Ranking Surges
- NewsAvi Kapoor
Why Richardson Electronics Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
- NewsAvi Kapoor
Nasdaq Gains 150 Points; US Mortgage Applications Decline
- NewsAvi Kapoor
Why Confluent Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
- News
Xenetic Biosciences Q4 EPS $(0.68) Misses $(0.20) Estimate, Sales $648.82K Beat $230.00K Estimate
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.